BR112015023672A2 - análogo de insulina, orto-fluoro, sequência de dna codificando a cadeia a de análogo de insulina, sequência de dna codificando a cadeia b de análogo de insulina e uso de um análogo de insulina. - Google Patents

análogo de insulina, orto-fluoro, sequência de dna codificando a cadeia a de análogo de insulina, sequência de dna codificando a cadeia b de análogo de insulina e uso de um análogo de insulina.

Info

Publication number
BR112015023672A2
BR112015023672A2 BR112015023672A BR112015023672A BR112015023672A2 BR 112015023672 A2 BR112015023672 A2 BR 112015023672A2 BR 112015023672 A BR112015023672 A BR 112015023672A BR 112015023672 A BR112015023672 A BR 112015023672A BR 112015023672 A2 BR112015023672 A2 BR 112015023672A2
Authority
BR
Brazil
Prior art keywords
insulin analog
chain
sequence encoding
dna sequence
insulin
Prior art date
Application number
BR112015023672A
Other languages
English (en)
Inventor
a weiss Michael
Original Assignee
Univ Case Western Reserve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Case Western Reserve filed Critical Univ Case Western Reserve
Publication of BR112015023672A2 publication Critical patent/BR112015023672A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR112015023672A 2013-03-15 2014-03-17 análogo de insulina, orto-fluoro, sequência de dna codificando a cadeia a de análogo de insulina, sequência de dna codificando a cadeia b de análogo de insulina e uso de um análogo de insulina. BR112015023672A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798165P 2013-03-15 2013-03-15
PCT/US2014/030387 WO2014145593A2 (en) 2013-03-15 2014-03-17 Site 2 insulin analogues

Publications (1)

Publication Number Publication Date
BR112015023672A2 true BR112015023672A2 (pt) 2017-07-18

Family

ID=51538504

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015023672A BR112015023672A2 (pt) 2013-03-15 2014-03-17 análogo de insulina, orto-fluoro, sequência de dna codificando a cadeia a de análogo de insulina, sequência de dna codificando a cadeia b de análogo de insulina e uso de um análogo de insulina.

Country Status (10)

Country Link
US (1) US20160083448A1 (pt)
EP (1) EP2968473A4 (pt)
JP (1) JP2016516728A (pt)
KR (1) KR20150138251A (pt)
CN (1) CN105228643A (pt)
AU (1) AU2014232894B2 (pt)
BR (1) BR112015023672A2 (pt)
CA (1) CA2942524A1 (pt)
IL (1) IL241357B (pt)
WO (1) WO2014145593A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102351111B1 (ko) 2014-01-13 2022-01-14 써멀린 다이어비티즈, 엘엘씨 초속효성 인슐린 제형 및 약제학적 전달 시스템
CN107428814A (zh) * 2015-01-20 2017-12-01 卡斯西部储备大学 具有选择性信号传导特性和降低的促有丝***性的胰岛素类似物
CR20190096A (es) 2016-07-22 2019-09-16 Walter & Eliza Hall Inst Medical Res Análogos de insulina
CN109891237B (zh) * 2016-10-24 2022-08-23 诺和诺德股份有限公司 胰岛素制剂的生物测定法
US11208453B2 (en) * 2016-11-21 2021-12-28 Case Western Reserve University Rapid-acting insulin analogues of enhanced stability
BR112021005366A2 (pt) * 2018-09-21 2021-06-29 Case Western Reserve University análogo de insulina de cadeia simples, uso deste e método para reduzir o açúcar no sangue de um paciente

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK158390D0 (da) * 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
DK33591D0 (pt) * 1991-02-27 1991-02-27 Novo Nordisk As
EP2049149B1 (en) * 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
ES2554773T3 (es) 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
WO2009129250A2 (en) * 2008-04-14 2009-10-22 Case Western Reserve University Meal-time insulin analogues of enhanced stability
EP2296692A4 (en) * 2008-04-22 2012-06-06 Univ Case Western Reserve INSULIN ANALOGUES SPECIFIC TO ISOFORMS
CN102171245B (zh) * 2008-07-31 2015-03-25 卡斯西部储备大学 卤素稳定型胰岛素

Also Published As

Publication number Publication date
IL241357A0 (en) 2015-11-30
US20160083448A1 (en) 2016-03-24
WO2014145593A3 (en) 2015-01-08
WO2014145593A2 (en) 2014-09-18
AU2014232894B2 (en) 2018-02-08
JP2016516728A (ja) 2016-06-09
KR20150138251A (ko) 2015-12-09
CN105228643A (zh) 2016-01-06
AU2014232894A1 (en) 2015-11-05
CA2942524A1 (en) 2014-09-18
EP2968473A4 (en) 2016-11-23
EP2968473A2 (en) 2016-01-20
IL241357B (en) 2021-08-31

Similar Documents

Publication Publication Date Title
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
DK3218392T3 (da) Makrocykliske peptider, der er anvendelige som immunmodulatorer
BR112016030968A2 (pt) análogos de pridopidina, preparação e uso destes
DK2963056T3 (da) Insulinanalog og anvendelse deraf
BR112016020618A2 (pt) oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
BR112016003229A2 (pt) Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
BR112018004976A2 (pt) Composição, borracha reticulada, e, gaxeta de coletor de admissão.
BR112015023672A2 (pt) análogo de insulina, orto-fluoro, sequência de dna codificando a cadeia a de análogo de insulina, sequência de dna codificando a cadeia b de análogo de insulina e uso de um análogo de insulina.
BR112014031412A2 (pt) método de preparação de uma composição, composição e seu uso, e kit.
DK3131497T3 (da) Instrumenter til anvendelse med implanterbare indkapslingsindretninger
DK3155017T3 (da) Forbedrede lægemidler til insulinresistens
DK3178928T3 (da) Pint-knockout-mus med en præmatur, aldersassocieret fænotype
FR3007989B1 (fr) Autoinjecteur.
EP3232486A4 (en) Ink composition for organic light-emitting element, and organic light-emitting element using same
FR3013601B1 (fr) Autoinjecteur.
BR112017000895A2 (pt) componente de mancal, mancal, uso de um componente de mancal, e uso de um mancal
DK3013147T3 (da) Sammensætninger, der omfatter pesticidprækursorer, samt fremgangsmåder til fremstilling og anvendelse deraf
DK3389701T3 (da) Nucleotidesekvens, der udtrykker et exosomforankrende, protein til anvendelse som vaccine
BR112013019030A2 (pt) válvula de retenção, e, uso de uma válvula de retenção.
BR112016021231A2 (pt) derivados de hexose, preparação e uso destes.
FI20165230A (fi) Katalysaattoriyksikkö ja pakokaasukatalysaattori
IS2968B (is) Skelflettibúnaður með endingargóðum fingraramma-kambkeflum
DK3076990T3 (da) Biologisk aktive insulinderivater
CL2016001961A1 (es) Levadura biológica, procedimiento de obtención y usos
BR112015030989A2 (pt) composição farmacêutica, e, uso de uma composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements